Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics.

dc.contributor.authorMontiel-Riquelme, Francisco
dc.contributor.authorCalatrava-Hernández, Elisabeth
dc.contributor.authorGutiérrez-Soto, Miguel
dc.contributor.authorExpósito-Ruiz, Manuela
dc.contributor.authorNavarro-Marí, José María
dc.contributor.authorGutiérrez-Fernández, José
dc.date.accessioned2025-01-07T14:30:02Z
dc.date.available2025-01-07T14:30:02Z
dc.date.issued2020-10-09
dc.description.abstractThe increasing resistance to antibiotics is compromising the empirical treatment of infections caused by resistant bacteria. Rapid, efficient, and clinically applicable phenotypic methods are needed for their detection. This study examines the phenotypic behavior of β-lactam-resistant Gram-negative bacteria grown on ChromID ESBL medium with ertapenem, cefoxitin, and cefepime disks, reports on the coloration of colonies, and establishes a halo diameter breakpoint for the detection of carbapenemase-producing bacteria. We studied 186 β-lactam-resistant Gram-negative microorganisms (77 with extended spectrum beta lactamase (ESBL), 97 with carbapenemases, and 12 with AmpC β-lactamases (AmpC)). Susceptibility profiles of Gram-negative bacteria that produced ESBL, AmpC, and carbapenemases were similar to the expected profiles, with some differences in the response to cefepime of ESBL-producing microorganisms. Coloration values did not differ from those described by the manufacturer of ChromID ESBL medium. In the screening of carbapenemase production, inhibition halo diameter breakpoints for antibiotic resistance were 18 mm for Enterobacterales and ertapenem, 18 mm for Pseudomonas and cefepime, and 16 mm for Acinetobacter baumannii and cefepime. This innovative phenotypic approach is highly relevant to clinical laboratories, combining susceptibility profiles with detection by coloration of high-priority resistant microorganisms such as carbapenemase-producing A. baumannii, carbapenemase-producing Pseudomonas spp., and ESBL and/or carbapenemase-producing Enterobacterales.
dc.identifier.doi10.3390/microorganisms8101555
dc.identifier.issn2076-2607
dc.identifier.pmcPMC7601678
dc.identifier.pmid33050170
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7601678/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2076-2607/8/10/1555/pdf?version=1602238455
dc.identifier.urihttps://hdl.handle.net/10668/26452
dc.issue.number10
dc.journal.titleMicroorganisms
dc.journal.titleabbreviationMicroorganisms
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAcinetobacter
dc.subjectEnterobacterales
dc.subjectPseudomonas
dc.subjectbeta-lactam antibiotics
dc.subjectresistance
dc.titleClinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7601678.pdf
Size:
1.94 MB
Format:
Adobe Portable Document Format